Home › Funds › Vivo Capital, LLC › CAMP

Vivo Capital, LLC position in CAMP

CAMP4 Therapeutics Corporation · Health Care

Vivo Capital, LLC reported holding 5,584,111 shares of CAMP (CAMP4 Therapeutics Corporation) in its Q3 2026 13F filing — a position valued at US$22.6M, representing 2.56% of its reported portfolio and ranking #14 among its reported holdings. Vivo Capital, LLC has disclosed CAMP holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)5.58M sh
Reported value held$22.56M
Portfolio Weight2.56%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's CAMP position evolved

Vivo Capital, LLC first disclosed a stake in CAMP in Q3 2025 at 3,921,568 shares (US$11.8M). The position peaked in Q4 2025 at 4,246,568 shares, worth US$26.0M. Across 5 filings, Vivo Capital, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 5,584,111 shares valued at US$22.6M — an increase of 1,337,543 shares quarter over quarter.. Notable position changes include a 31% increase in Q3 2026 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 3.92M $11.76M New
Q4 2025 4.25M $26.03M Add
Q1 2026 4.25M $18.73M Hold
Q2 2026 4.25M $18.56M Hold
Q3 2026 5.58M $22.56M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAMP and 13F data

CAMP (CAMP4 Therapeutics Corporation) is a Health Care company. 36 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), a16z Capital Management, L.L.C. (US$9.3M), Trails Edge Capital Partners, LP (US$8.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAMP

All CAMP fund holders →

FAQ

How long has Vivo Capital, LLC held CAMP?

Vivo Capital, LLC has disclosed CAMP holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Vivo Capital, LLC's current position in CAMP?

As of Q3 2026, Vivo Capital, LLC holds 5.58M shares of CAMP (CAMP4 Therapeutics Corporation), valued at $22.56M, representing 2.56% of its reported portfolio and ranking #14.

Has Vivo Capital, LLC been buying or selling CAMP?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC increased its position in CAMP. The position peaked in Q4 2025 at 4.25M shares.

Which other funds hold CAMP?

Other major institutional holders of CAMP include 5AM Venture Management, LLC, a16z Capital Management, L.L.C., Trails Edge Capital Partners, LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.